Literature DB >> 18641256

Hyperpolarized 3He MR imaging: physiologic monitoring observations and safety considerations in 100 consecutive subjects.

Barbara A Lutey1, Stephen S Lefrak, Jason C Woods, Tariq Tanoli, James D Quirk, Adil Bashir, Dmitriy A Yablonskiy, Mark S Conradi, Seth T Bartel, Thomas K Pilgram, Joel D Cooper, David S Gierada.   

Abstract

PURPOSE: To evaluate the safety of hyperpolarized helium 3 ((3)He) magnetic resonance (MR) imaging.
MATERIALS AND METHODS: Local institutional review board approval and informed consent were obtained. Physiologic monitoring data were obtained before, during, and after hyperpolarized (3)He MR imaging in 100 consecutive subjects (57 men, 43 women; mean age, 52 years +/- 14 [standard deviation]). The subjects inhaled 1-3 L of a gas mixture containing 300-500 mL (3)He and 0-2700 mL N(2) and held their breath for up to 15 seconds during MR imaging. Heart rate and rhythm and oxygen saturation of hemoglobin as measured by pulse oximetry (Spo(2)) were monitored continuously throughout each study. The effects of (3)He MR imaging on vital signs and Spo(2) and the relationship between pulmonary function, number of doses, and clinical classification (healthy volunteers, patients with asthma, heavy smokers, patients undergoing lung volume reduction surgery for severe emphysema, and patients with lung cancer) and the lowest observed Spo(2) were assessed. Any subjective symptoms were noted.
RESULTS: Except for a small postimaging decrease in mean heart rate (from 78 beats per minute +/- 13 to 73 beats per minute +/- 11, P < .001), there was no effect on vital signs. A mean transient decrease in Spo(2) of 4% +/- 3 was observed during the first minute after gas inhalation (P < .001) in 77 subjects who inhaled a dose of 1 L for 10 seconds or less, reaching a nadir of less than 90% at least once in 20 subjects and of less than 85% in four subjects. There was no correlation between the lowest Spo(2) and pulmonary function parameters other than baseline Spo(2) (r = 0.36, P = .001). The lowest mean Spo(2) varied by 1% between the first and second and second and third doses (P < .001) and was unrelated to clinical classification (P = .40). Minor subjective symptoms were noted by 10 subjects. No serious adverse events occurred.
CONCLUSION: Hyperpolarized (3)He MR imaging can be safely performed in healthy subjects, heavy smokers, and those with severe obstructive airflow limitation, although unpredictable transient desaturation suggests that potential subjects should be carefully screened for comorbidities.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18641256      PMCID: PMC2797647          DOI: 10.1148/radiol.2482071838

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  30 in total

1.  Lung air spaces: MR imaging evaluation with hyperpolarized 3He gas.

Authors:  E E de Lange; J P Mugler; J R Brookeman; J Knight-Scott; J D Truwit; C D Teates; T M Daniel; P L Bogorad; G D Cates
Journal:  Radiology       Date:  1999-03       Impact factor: 11.105

2.  ATS statement: guidelines for the six-minute walk test.

Authors: 
Journal:  Am J Respir Crit Care Med       Date:  2002-07-01       Impact factor: 21.405

3.  Assessment of lung disease in children with cystic fibrosis using hyperpolarized 3-Helium MRI: comparison with Shwachman score, Chrispin-Norman score and spirometry.

Authors:  Edwin J R van Beek; Catherine Hill; Neil Woodhouse; Stanislao Fichele; Sally Fleming; Bridget Howe; Sandra Bott; Jim M Wild; Christopher J Taylor
Journal:  Eur Radiol       Date:  2006-08-29       Impact factor: 5.315

Review 4.  Hyperpolarized 3-helium magnetic resonance imaging to probe lung function.

Authors:  Edwin J R van Beek; Jim M Wild
Journal:  Proc Am Thorac Soc       Date:  2005

5.  Acinar structure in symptom-free adults by Helium-3 magnetic resonance.

Authors:  Barnaby Waters; John Owers-Bradley; Mike Silverman
Journal:  Am J Respir Crit Care Med       Date:  2006-01-26       Impact factor: 21.405

6.  Hyperpolarized 3helium magnetic resonance ventilation imaging of the lung in cystic fibrosis: comparison with high resolution CT and spirometry.

Authors:  Colm J McMahon; Jonathan D Dodd; Catherine Hill; Neil Woodhouse; Jim M Wild; Stan Fichele; Charles G Gallagher; Stephen J Skehan; Edwin J R van Beek; James B Masterson
Journal:  Eur Radiol       Date:  2006-07-27       Impact factor: 5.315

7.  Nuclear relaxation of 3He in the presence of O2.

Authors: 
Journal:  Phys Rev A       Date:  1995-07       Impact factor: 3.140

8.  Hyperpolarized HHe 3 MRI of the lung in cystic fibrosis: assessment at baseline and after bronchodilator and airway clearance treatment.

Authors:  Kimiknu Mentore; Deborah K Froh; Eduard E de Lange; James R Brookeman; Alix O Paget-Brown; Talissa A Altes
Journal:  Acad Radiol       Date:  2005-11       Impact factor: 3.173

9.  Hyperpolarized 3He diffusion MRI and histology in pulmonary emphysema.

Authors:  Jason C Woods; Cliff K Choong; Dmitriy A Yablonskiy; John Bentley; Jonathan Wong; John A Pierce; Joel D Cooper; Peter T Macklem; Mark S Conradi; James C Hogg
Journal:  Magn Reson Med       Date:  2006-12       Impact factor: 4.668

10.  Quantitative analysis of regional airways obstruction using dynamic hyperpolarized 3He MRI-preliminary results in children with cystic fibrosis.

Authors:  Panos Koumellis; Edwin J R van Beek; Neil Woodhouse; Stan Fichele; Andrew J Swift; Martyn N J Paley; Catherine Hill; Chris J Taylor; Jim M Wild
Journal:  J Magn Reson Imaging       Date:  2005-09       Impact factor: 4.813

View more
  30 in total

Review 1.  Lung imaging in asthmatic patients: the picture is clearer.

Authors:  Mario Castro; Sean B Fain; Eric A Hoffman; David S Gierada; Serpil C Erzurum; Sally Wenzel
Journal:  J Allergy Clin Immunol       Date:  2011-06-02       Impact factor: 10.793

2.  Safety of repeated hyperpolarized helium 3 magnetic resonance imaging in pediatric asthma patients.

Authors:  Nanae Tsuchiya; Mark L Schiebler; Michael D Evans; Robert V Cadman; Ronald L Sorkness; Robert F Lemanske; Daniel J Jackson; Nizar N Jarjour; Loren C Denlinger; Sean B Fain
Journal:  Pediatr Radiol       Date:  2020-01-24

3.  Imaging alveolar-duct geometry during expiration via ³He lung morphometry.

Authors:  A J Hajari; D A Yablonskiy; J D Quirk; A L Sukstanskii; R A Pierce; G Deslée; M S Conradi; J C Woods
Journal:  J Appl Physiol (1985)       Date:  2011-02-24

4.  In vivo detection of acinar microstructural changes in early emphysema with (3)He lung morphometry.

Authors:  James D Quirk; Barbara A Lutey; David S Gierada; Jason C Woods; Robert M Senior; Stephen S Lefrak; Alexander L Sukstanskii; Mark S Conradi; Dmitriy A Yablonskiy
Journal:  Radiology       Date:  2011-07-06       Impact factor: 11.105

5.  In vivo lung morphometry with hyperpolarized (3) He diffusion MRI: reproducibility and the role of diffusion-sensitizing gradient direction.

Authors:  James D Quirk; Yulin V Chang; Dmitriy A Yablonskiy
Journal:  Magn Reson Med       Date:  2014-04-21       Impact factor: 4.668

6.  Novel Thoracic MRI Approaches for the Assessment of Pulmonary Physiology and Inflammation.

Authors:  Jonathan P Brooke; Ian P Hall
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

7.  Feasibility, tolerability and safety of pediatric hyperpolarized 129Xe magnetic resonance imaging in healthy volunteers and children with cystic fibrosis.

Authors:  Laura L Walkup; Robert P Thomen; Teckla G Akinyi; Erin Watters; Kai Ruppert; John P Clancy; Jason C Woods; Zackary I Cleveland
Journal:  Pediatr Radiol       Date:  2016-08-05

8.  Chronic obstructive pulmonary disease: safety and tolerability of hyperpolarized 129Xe MR imaging in healthy volunteers and patients.

Authors:  Bastiaan Driehuys; Santiago Martinez-Jimenez; Zackary I Cleveland; Gregory M Metz; Denise M Beaver; John C Nouls; S Sivaram Kaushik; Rafael Firszt; Christine Willis; Kevin T Kelly; Jan Wolber; Monica Kraft; H Page McAdams
Journal:  Radiology       Date:  2011-11-04       Impact factor: 11.105

9.  Quantitative analysis of hyperpolarized 129Xe ventilation imaging in healthy volunteers and subjects with chronic obstructive pulmonary disease.

Authors:  Rohan S Virgincar; Zackary I Cleveland; S Sivaram Kaushik; Matthew S Freeman; John Nouls; Gary P Cofer; Santiago Martinez-Jimenez; Mu He; Monica Kraft; Jan Wolber; H Page McAdams; Bastiaan Driehuys
Journal:  NMR Biomed       Date:  2012-10-13       Impact factor: 4.044

10.  Effects of diffusion time on short-range hyperpolarized (3)He diffusivity measurements in emphysema.

Authors:  David S Gierada; Jason C Woods; Andrew J Bierhals; Seth T Bartel; Jon H Ritter; Cliff K Choong; Nitin A Das; Cheng Hong; Thomas K Pilgram; Yulin V Chang; Richard E Jacob; James C Hogg; Richard J Battafarano; Joel D Cooper; Bryan F Meyers; G Alexander Patterson; Dmitriy A Yablonskiy; Mark S Conradi
Journal:  J Magn Reson Imaging       Date:  2009-10       Impact factor: 4.813

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.